Alistair Milnes
Fortune : 436 394 $ au 30/06/2026
Fortune : 436 394 $ au 30/06/2026
Alistair Milnes is currently an Independent Director at Femasys, Inc. since 2023 and Chief Corporate Development Officer at Bicycle Therapeutics Plc since 2021.
Formerly, Mr. Milnes was Director-Global Human Resources and Communications at SEFE Marketing & Trading Ltd. from 2017 to 2019.
Education includes an undergraduate degree from Edinburgh Napier University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 102 923 ( 0,27 % ) | 436 394 $ | 30/06/2026 | |
FEMASYS, INC. -.--% | 15/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 17/03/2026 |
| FEMASYS INC. | Directeur/Membre du Conseil | 14/06/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
SEFE Marketing & Trading Ltd.
SEFE Marketing & Trading Ltd. Investment Banks/BrokersFinance Provides commodity trading services | Public Communications Contact | 01/10/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Femasys, Inc.
Femasys, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a medical device company that focuses on women''s healthcare | Electronic Technology |
SEFE Marketing & Trading Ltd.
SEFE Marketing & Trading Ltd. Investment Banks/BrokersFinance Provides commodity trading services | Finance |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Edinburgh Napier University
Edinburgh Napier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national